Navigation Links
Bioniche Converts a Portion of its Debt to Equity
Date:3/27/2008

- results in US$1.75 million of new available funds -

BELLEVILLE, ON, March 27 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that the Company has exercised its right under the agreement to repay US$1.75 million of its secured revolving credit facility with Valens U.S. (formerly Laurus Master Funds) in common shares.

The conversion is in accordance with the formula set out in the original agreement signed in 2005. The shares will be priced at the ten day market average less 15% which equates to 2,671,900 shares. In addition, the Company will issue 200,000 five-year warrants at market price ($0.77 per share) in exchange for Valens waiving certain volume restrictions relating to the conversion under the agreement. There is no penalty attached to this repayment.

This conversion will result in new available funds of US$1.75 million. As a result, the Company's capacity to borrow under the revolving credit facility after the conversion will be approximately US$3.2M, determined by a formula which measures existing levels of inventory and accounts receivable.

"Again we appreciate the support and flexibility of our bankers, Valens U.S.," said Patrick Montpetit, Chief Financial Officer of Bioniche Life Sciences Inc. "This private placement will improve our liquidity as we continue to execute our Phase III clinical development program with Urocidin in bladder cancer and begin the construction of a facility in which to scale-up production of our E. coli O157:H7 cattle vaccine in Belleville, Ontario."

About Bioniche Life Sciences Inc.

Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximatel
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Bioniche Receives Fast Track Designation For First-Line Bladder Cancer Therapy
2. Bioniche Pharma Chooses TrackWise for its Deviation Control Solution
3. Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin(TM)
4. Bioniche Reports Fiscal 2008 Second Quarter
5. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
6. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
7. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
8. Bioniche Reports Fiscal 2008 First Quarter
9. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
10. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
11. Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... ... ... BeverlyD, owner and founder of BeverlyD Luxe Organic Hair Care, has announced her ... to kick off the campaign for healing and Well-Being. , BeverlyD has helped women ... of raw, organic hair care products, as well as her book, Hair Now!— The ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reputable source of authentic tickets ... Garden Arena. Fans of every genre of music will have an act they are ... day of the festival, the following artists will perform: Sam Smith, Coldplay, Kenny Chesney, ...
(Date:7/31/2015)... ... ... Ticket Down is a reliable source for authentic tickets for the 2015 ... festival will end on Sunday, August 2nd. , Music fans have traveled ... unique and unbelievably popular festival attracts the best in entertainment from around the world. ...
(Date:7/31/2015)... ... July 31, 2015 , ... The 2nd annual Ride to Fight On ... on October 3, 2015. The Ride to Fight On is a cycling fundraiser that ... Healthcare, The West Clinic and The University of Tennessee Health Science Center. A health ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... Group, Inc. has re-branded their social media profiles to better connect with the ... consumers to communicate, find information, share insights and opinions. The Rally Insurance Group, ...
Breaking Medicine News(10 mins):Health News:March4thforWellBeing Foundation Kickoff 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2
... Jeffrey A. Toretsky, M.D., a pediatric oncology physician ... Center has received a prestigious Clinical Scientist Award ... (BWF). The $750,000 award, one of only 13 ... independent physician-scientists who are dedicated to translational research ...
... Medicare Strike Force, WASHINGTON, March 7 A ... and operators of two durable medical,equipment companies and a ... Alice S. Fisher of the Criminal Division and,U.S. Attorney ... today., After a five week trial in Miami, ...
... Longs Drug,Stores Corporation (NYSE: LDG ) today ... vice president and chief operating officer, effective,immediately. He ... Vasos will,be responsible for store operations, marketing, merchandising, ... 2001 as senior vice president of marketing. He,was ...
... activates p53 tumor-suppressor function without causing DNA damage , , ... targets a protein interaction involved in many types of ... , In cell cultures, the small-molecule inhibitor MI-219 was ... protein p53 from being blocked in the presence of ...
... This release is available in Spanish . , ... Health from the University of Granada have ... conclusion they have come to is that an efficient response ... of the cases caused by three of the most frequent ...
... Telehealth capabilities to the ... help across Canada., TORONTO, March 7 /PRNewswire/ - Healthanywhere, ... they have partnered with We,Care Health Services Inc. "We Care" ... services for those with chronic diseases,and their caregivers. We Care ...
Cached Medicine News:Health News:Lombardi Cancer Center's Toretsky awarded prestigious Burroughs Wellcome Fund Award 2Health News:Miami Jury Convicts Physician and Three Business Owners of Medicare Fraud 2Health News:Miami Jury Convicts Physician and Three Business Owners of Medicare Fraud 3Health News:Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 2Health News:Researchers Design Promising Cancer Drug 2Health News:An efficient response in primary care would reduce the use of hospitals by elderly people 2Health News:We Care Health Services Inc. partners with IgeaCare Systems Inc. to deliver Healthanywhere(TM) for Chronic Disease Management in Canada. 2Health News:We Care Health Services Inc. partners with IgeaCare Systems Inc. to deliver Healthanywhere(TM) for Chronic Disease Management in Canada. 3
(Date:7/31/2015)... , July 31, 2015 ... decades of experience, the domestic pharmaceutical industry is strong, ... manufacture products to high international standards. One ... known is in sub-Saharan Africa: Morocco has quietly become ... South Africa . Indeed, Moroccan pharma ...
(Date:7/31/2015)... 31, 2015  Xencor, Inc. (NASDAQ: XNCR ), ... the treatment of autoimmune diseases, asthma and allergic diseases, ... S. Hata to its board of directors. ... corporate development is a tremendous asset to our board," ... executive officer of Xencor. "Xencor faces a range of ...
(Date:7/30/2015)... International Inc. (NYSE: MTD ) today announced second ... , Sales in local currency increased 3% ... sales decreased 4% as currency reduced sales growth by ... diluted share as reported (EPS) were $2.73, compared with ... , an increase of 9% over the prior-year ...
Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14
... Feb. 19 A natural health company located ... results of,recent clinical studies indicating their oxygen colon ... and Irritable Bowel,Syndrome. In fact, the scientific data ... 85% MORE EFFECTIVE AT ELIMINATING SYMPTOMS,THAN TRADITIONAL LAXATIVES ...
... Feb. 19 Compendia Bioscience, Inc.,today announced results ... expanding commitment from all major customers and the ... its customer roster. The new,customers and existing customer ... increase, with similar growth forecasted for 2008., ...
Cached Medicine Technology:Oxygen Relieves IBS and Constipation Symptoms in New Clinical Studies 2On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments 2On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments 3
... many patients with a diseased heart, the only therapy ... heart transplant. However, donor organs are not always readily ... they are on the waiting list for a donor ... can save the life of a patient. On the ...
... InstaTest AFP is an immunochromatographic in ... protein (AFP) in human serum. AFP is ... 67,000 to 74,000 D. Its normal concentration ... concentrations are associated with hepatoma and ovarian, ...
... STA Compact is a ... coagulation analyser for clotting, ... based .coagulation tests.The medium-throughput ... of primary tubes, 45 ...
... Our high-quality MPD Lancets are designed with ... the tri-bevel, thin gauge needle with its ... smoother, less painful penetration without tearing the ... body is easy to grip, even for ...
Medicine Products: